SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 79.09 |
| Enterprise Value ($M) | 67.47 |
| Book Value ($M) | 16.77 |
| Book Value / Share | 0.31 |
| Price / Book | 4.72 |
| NCAV ($M) | 11.10 |
| NCAV / Share | 0.20 |
| Price / NCAV | 7.12 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.11 |
| Return on Assets (ROA) | -0.62 |
| Return on Equity (ROE) | -1.66 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.01 |
| Current Ratio | 4.07 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 165.25 |
| Assets | 170.91 |
| Liabilities | 154.14 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 30.99 |
| Operating Income | -131.49 |
| Net Income | -141.41 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -118.00 |
| Cash from Investing | -28.61 |
| Cash from Financing | 26.63 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Citadel Advisors Llc | 0.40 | ||
| 13G | Tang Capital Partners Lp | 8.20 | ||
| 13G/A | Eventide Asset Management, Llc | 8.30 | 43.81 | |
| 13G/A | Cormorant Asset Management, LP | 5.96 | 16.07 | |
| 13G/A | Avoro Capital Advisors LLC | 5.80 | 0.00 | |
| 13G/A | Lion Point Capital, LP | 3.90 | -55.35 | |
| 13G/A | Point72 Asset Management, L.P. | 0.90 | -85.96 | |
| 13G/A | Suvretta Capital Management, Llc | 9.99 | 9.90 | |
| 13G | Prudential Financial Inc | 6.07 | 209,393.10 | |
| 13G | Jennison Associates Llc | 5.40 | ||
| 13G/A | Adage Capital Partners Gp, L.l.c. | 4.73 | -6.35 | |
| 13G | Franklin Resources Inc | 7.00 | 65.43 | |
| 13G | BlackRock Inc. | 8.40 | 388.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 285,784 | 1,124,814 | 25.41 | |
| 308,834 | 1,651,847 | 18.70 | |
| 615,050 | 602,461 | 102.09 | |
| 482,692 | 652,406 | 73.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MNKD – MannKind Corporation | MNOV – MediciNova, Inc. |
| MORF – Morphic Holding, Inc. | MRUS – Merus N.V. |
| MURA – Mural Oncology plc |